Know Cancer

or
forgot password
  • cancer clinical trials in new brunswick, NJ

  • Exatecan Mesylate in Treating Children With Relapsed or Refractory Rhabdomyosarcoma
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Sarcoma
    TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
    The Cancer Institute of New Jersey

    Trial Locations
    The Cancer Institute of New Jersey
    Robert Wood Johnson University Hospital
    Ovarian Neoplasms
    Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Pancreatic Cancer
    Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Lymphoma
    Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Sarcoma
    Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Metastatic Cancer, Sarcoma
    Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma With Sarcomatoid Features
    Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Vulvar Cancer
    Safety and Activity of SDX-105 (Bendamustine) in Patients With Rituximab Refractory Non-Hodgkin's Lymphoma
    The Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Non-Hodgkin's Lymphoma
    Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Leukemia
    Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
    UMDNJ - Robert Wood Johnson University Hospital
    New Brunswick, New Jersey 08903
    Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Bortezomib in Treating Patients With Newly Diagnosed High-Risk Stage III Multiple Myeloma
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Multiple Myeloma, Plasma Cell Neoplasm
    SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)
    The Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Non-Hodgkin's Lymphoma
    Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Breast Cancer
    Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer
    Local Institution
    New Brunswick, New Jersey
    Breast Cancer, Metastases
    Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    Central Jersey Oncology Center
    New Brunswick, New Jersey 08901
    Non Small Cell Lung Carcinoma
    Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer
    Cancer Institute of New Jersey - University of Medicine and Dentistry of New Jersey
    New Brunswick, New Jersey 08903
    Neoplasm
    hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Neuroblastoma
    Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary CNS Germ Cell Tumor
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    Brain Tumor, Central Nervous System Tumor
    Study of Individualized Amonafide to Treat Prostate Cancer
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Prostate Cancer
    MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma
    The Cancer Institute of New Jersey

    Trial Locations
    The Cancer Institute of New Jersey
    Robert Wood Johnson University Hospital
    Melanoma, Metastases
    Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Epratuzumab and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia
    UMDNJ - Robert Wood Johnson University Hospital
    New Brunswick, New Jersey 08903
    Recurrent Childhood Acute Lymphoblastic Leukemia
    Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced Cancer
    Cancer Institute of New Jersey - University of Medicine and Dentistry of New Jersey
    New Brunswick, New Jersey 08903
    Neoplasm
    Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
    Saint Peter's University Hospital
    New Brunswick, New Jersey 08901-1780
    Brain and Central Nervous System Tumors
    Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Breast Cancer
    Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Mesothelioma
    Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
    Local Institution
    New Brunswick, New Jersey
    Chronic Myeloid Leukemia, Leukemia, Lymphoblastic, Acute, Philadelphia-positive
    Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia
    Local Institution
    New Brunswick, New Jersey
    Chronic Myelogenous Leukemia
    Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib
    Local Institution
    New Brunswick, New Jersey
    Chronic Myeloid Leukemia, Philadelphia-Positive Myeloid Leukemia
    TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer
    The Cancer Institute of New Jersey

    Trial Locations
    The Cancer Institute of New Jersey
    Robert Wood Johnson University Hospital
    Ovarian Neoplasms
    A Multiple Myeloma Trial in Patients With Bone Metastases
    Central Jersey Oncology Center
    New Brunswick, New Jersey 08901
    Multiple Myeloma
    Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    Breast Cancer
    Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    Lung Cancer
    Study of XL820 in Adults With Solid Tumors
    The Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Cancer
    Isotretinoin, Interferon Alfa-2b, and Paclitaxel in Treating Patients With Stage IV, Recurrent, or Persistent Cervical Cancer
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    Cervical Cancer
    Esophageal Metaplasia Using a Novel Antibody: Reversibility by Proton Pump Inhibitor
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Esophageal Metaplasia
    Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    Central Jersey Oncology Group
    Pancreatic Cancer
    Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among Elderly
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Prostate Cancer
    Clinical Study of Ixabepilone Administered as a 24 Hour Infusion in Patients With Solid Malignancies.
    The Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Solid Malignancies
    A Phase I Open Label Study of E7974 Administered on a Day 1 of 21-Day Cycle In Patients With Advanced Solid Tumors
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Cancer, Malignant Tumors
    CINJALL: Treatment for Children With Acute Lymphocytic Leukemia
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Acute Lymphocytic Leukemia
    Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm
    Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Breast Cancer